Vertaling van "from operating activities as determined under " (Nederlands → Frans) :

Free cash flow is not intended to be a substitute measure for cash flow from operating activities as determined under IFRS.
Le free cash flow ne vise pas à se substituer, en tant que mesure, au flux de trésorerie provenant des activités opérationnelles, tel qu'il est défini par les normes IFRS.

Free cash flow is not intended to be a substitute measure for cash flow from operating activities (as determined under IFRS).
Le free cash flow ne vise pas à se substituer, en tant que mesure, au flux de trésorerie provenant des activités opérationnelles (tel qu'il est défini par les IFRS).

Fourth quarter Q4 2009 Q4 2008 Change USD m USD m USD m Cash flow from operating activities from continuing operations 4 466 3 204 1 262
Free cash-flow avant dividendes 9 446 7 646 1 800 Dividendes payés aux actionnaires de Novartis AG –3 941 –3 345 –596

Cash flow Cash flow from operating activities for the first nine months rose USD 1.8 billion to USD 9.5 billion based on higher earnings from operations.
Flux de trésorerie Au cours des neuf premiers mois de l’année, les flux de trésorerie provenant des activités opérationnelles ont augmenté d’USD 1,8 milliard à USD 9,5 milliards, grâce à une hausse des revenus des opérations.

Cash flow Cash flow from operating activities from continuing operations rose 29% to USD 4.6 billion in the first half of 2009 compared to the year-ago period as a result of improved working capital management as well as lower financial and tax payments in the first six months of 2009 compared to the prior-year period.
Flux de trésorerie Au premier semestre 2009, les flux de trésorerie provenant des activités opérationnelles liées aux activités poursuivies ont progressé à USD 4,6 milliards, en hausse de 29% par rapport au premier semestre 2008. Cette progression résulte d’une amélioration de la gestion des fonds de roulement ainsi que d’une baisse des paiements financiers et fiscaux au premier semestre 2009, par rapport à la période correspondante de 2008.

Second quarter Q2 2009 Q2 2008 Change USD m USD m USD m Cash flow from operating activities from continuing operations 2 618 1 852 766
Deuxième trimestre T2 2009 T2 2008 Variation M USD M USD M USD Variation de la trésorerie et des équivalents de trésorerie 2 015 7 138 –5 123

Cash flow from operating activities from continuing operations 9 769 9 210 559
Flux de trésorerie provenant des activités opérationnelles des activités poursuivies 9 769 9 210 559

“Comparative cost analysis: Community based services as an alternative to institutions" , tender no. VT/2005/021, Official Journal on 22 June 2005 N° 2005/S 119-117014 [http ...]
K. ; Paul R (Hrsg.) : Health Promoting Hospitals in Practice: Developing Projects and Networks – Conrad, Gamburg Inclusion Europe, Included in Society (2003-2004), projet réalisé dans le contexte du Fonds social européen ( [http ...]

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines